Eye, Ear & Nasal Preparations

Showing all 12 results

  • Betamethasone Sodium

    “Composition: Betamethasone Sodium Phosphate B.P….0.1% w/v. INDICATIONS: Betamethasone has topical corticosteroid activity and is indicated in non-infected inflammatory conditions of the eye, ear & nose. Eye: Non-infected inflammatory conditions (e.g. Uveitis, marginal keratitis, allergic conjunctivitis, blepharitis and episcleritis).
    Ear: Otitis Externa and other Inflammatory conditions. Nose: Allergic rhinitis and other inflammatory conditions. DOSAGE AND ADMINISTRATION:
    Eye:
    1or 2 drops instilled into the eye every one or two hours until control is achieved, then the frequency may be reduced.

    Ear:
    2 or 3 drops instilled into the ear every two or three hours until control is achieved, then the frequency may be reduced.
    Nose: 2 or 3 drops instilled into each nostril two or three times daily.”

  • Betamethasone Sodium

    COMPOSITION:

    Betamethasone Sodium Phosphate B.P …0.1% w / v

    INDICATIONS:

    Betasol Nasal Spray is recommended for use in the treatment of allergic, rhinitis, inflammatory, and congestive conditions of the nose. Allergic rhinitis is inflammation of the inside of the nose caused by an allergen, such as pollen, dust, mould or flakes of skin from certain animals

    DOSE AND ADMINISTRATION:

    2 to 3 times spray and to each nostril daily. Or as directed by the physician

  • Betamethasone Sodium + Neomycin

    Composition:

    Betamethasone Sodium Phosphate B.P….0.1% w/v
    Neomycin Sulphate B.P… 0.5% w/v                                  

    Indications:

    Eye: Non-Infected steroid responsive Inflammatory Conditions e.g. Uveitis, Marginal keratitis, Allergic conjunctivitis, Blepharitis, Episcleritis. Where prophylaxis against secondary bacterial infection is desired.                      

     Ear:

    Otitis externa and other steroid responsive inflammatory conditions where bacterial infection is present or suspected.
    Otitis externa is an inflammation of the ear canal. The inflammation may be caused by infection, allergy or other causes. Treatment with ear drops is usually effective.  Nose: Allergic rhinitis and other inflammatory conditions.

    Dosage and Administration:

    Eye: 1 or 2 drops instilled into the eye every one or two hours until signs of improvement are apparent, then the frequency may be reduced.
    Ear: 2 or 3 drops instilled into the ear every two or three hours until signs of improvement are apparent, then the frequency can be reduced.  Nose: 2 or 3 drops instilled into each nostril two or three times daily.

  • Chloramphenicol

    COMPOSITION:

    Each ml contains: Chloramphenicol BP……..10mg

    INDICATIONS:

    Bacterial infection of the outer ear canal (Bacterial Otitis externa) Caused by organisms susceptible to chloramphenicol.Acute Otitis Media
    • Common in children
    • Unwell/pyrexia, otalgia/discharge
    • there may be tenderness over the mastoid
    • discharge in meatus
    • loss of outline of drum and landmarks
    • TM: red, bulging, oedematous or perforation.
    • Mostly viral but can be Streptococcus/Haemophilus

    Dosage and Administration:

    1 to 3 drops every 4 hourly or as directed by the physician.

  • Chloramphenicol

    COMPOSITION:

    Each ml contains:
    Chloramphenicol BP……..5mg

    INDICATIONS:

    Acute Microbial Bacterial Conjunctivitis.
    Ulcerous Keratitis
    Microbial Infections of Lacrimal dust
    Microbial Blepharitis
    Infection of enucleation socket

    Dosage and Administration:

     The recommended dosage is for adults, and children aged 2 years and over.
    One drop to be applied to the infected eye every 2 hours for the first 48 hours and then every 4 hours thereafter. Treatment should be continued for 5 days.

  • Ciprofloxacin HCI

    Composition:

    Each ml contains:
    Ciprofloxacin USP 3mg        Action: Ciprofloxacin is a fluoroquinolone antibacterial active against a broad spectrum of gram-positive and gram-negative ocular pathogens.

    Indications:

    CIPRO is indicated for the treatment if infections caused by the susceptible strains of micro-organisms in the conditions listed below:
    Corneal Ulcer: Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus  pneumoniae, Streptococcus (Viridans Group.)
    Conjunctivitis: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae (Efficacy for this organism was studied in fewer than 10 infections.)

    Dosage & administration:

    Corneal Ulcers: Two drops into the affected eye every 15 minutes for the first six hours, then two drops every 30 minutes for the rest of first day. On the second day, two drops every hour. On the third through 14th day, two drops every four hours, Treatment may be continued after 14 days in corneal re-epithielialization has not occurred.

    Bacterial Conjunctivitis:

    One or two drops into conjunctival sac(s) every two hours while awake for two day and every four hours for the next five days during waking hours.

  • Gentamicin Sulphate

    Composition:

    Each ml Contains:
    Gentamicin BP… 3mg (as Gentamicin Sulphate)

    Indications:

    As a broad spectrum antibiotic for the topical treatment of eye and ear infections in corneal ulcers, bacterial conjunctivitis, trachoma and other ocular infection may be used post-operatively. Indicated in the topical treatment of eye infections caused by susceptible bacteria and also used in bacterial ear infections. . G-mycin eye/ear drops is also indicated for treatment of bacterial infection of otitis externa. It can also be used prophylactically removal of foreign bodies.

    Dosage and Administration:

    Eye: 1-2 drops to be instilled 3-6 times a day.
    Ear: 2-3 drops to be instilled 3-4 times a day in each ear.
    In severe cases dosage may be increased.

  • Neomycin + Polymyxin B + Dexamethasone

    Composition:

    Each ml contain: Neomycin sulphate 3.5mg + Polymyxin B sulphate 6,000 units + Dexamethasone sodium phosphate 1.0mg.                                              

    Indication:

    For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitis is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies.The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye.
    The particular anti-infective drug in this product is active against the following common bacterial eye pathogens: Staphylococcus aureus, Escherichia coli, Haemophilus influenzae, Klebsiella/Enterobacter species, Neisseria species, Pseudomonas aeruginosa.This product does not provide adequate coverage against Serratia marcescens, and Streptococci, including Streptococcus pneumoniae.

    DOSAGE AND ADMINISTRATION:

    One or two drops topically in the conjunctival sac(s). In severe disease, drops may be used hourly, being tapered to discontinuation as the inflammation subsides. In mild disease, drops may be used up to four to six times daily.

  • Ofloxacin

    Composition:

    Each ml contains:
    Ofloxacin B.P. 3mg

    Indication:

    Ofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below:

    CONJUNCTIVITIS:

    Gram-positive bacteria: Gram-negative bacteria:
    Staphylococcus aureus Enterobacter cloacae
    Staphylococcus epidermidis Haemophilus influenzae
    Streptococcus pneumoniae Proteus mirabilis
    Pseudomonas aeruginosa

    CORNEAL ULCERS:

    Gram-positive bacteria: Gram-negative bacteria:
    Staphylococcus aureus Pseudomonas aeruginosa
    Staphylococcus epidermidis Serratia marcescens*
    Streptococcus pneumoniae Anaerobic species:
    Propionibacterium acnes
    *Efficacy for this organism was studied in fewer than 10 infections

    Dosage and Administrations:

    The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
    Days 1 and 2 Instill one to two drops every two to four hours in the affected eye(s).
    Days 3 through 7 Instill one to two drops four times daily.
    The recommended dosage regimen for the treatment of bacterial corneal ulcer is:
    Days 1 and 2 Instill one to two drops into the affected eye every 30 minutes, while awake. Awaken at approximately four and six hours after retiring and instill one to two drops.
    Days 3 through 7 to 9
    treatment completion Instill one to two drops hourly, while awake.

  • Ofloxacin + Dexamethasone

    Composition:

    Each ml contains:
    Ofloxacin B.P. 3mg
    Dexamethasone as Sodium Phosphate B.P. 1mg

    Indications:

    Quiflocin Plus Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria where every inflammation and infection co-exists to decrease in edema and inflammation is needed mainly for post cataract inflammation control. Also for steroid responsive inflammation of the palpebral conjunctiva and anterior segment of the globe. Listed of the bacteria conditions as below:

    CONJUNCTIVITIS:

    Gram-positive bacteria: Gram-negative bacteria:
    Staphylococcus aureus Enterobacter cloacae
    Staphylococcus epidermidis Haemophilus influenzae
    Streptococcus pneumoniae Proteus mirabilis
    Pseudomonas aeruginosa

    CORNEAL ULCERS:

    Gram-positive bacteria: Gram-negative bacteria:
    Staphylococcus aureus Pseudomonas aeruginosa
    Staphylococcus epidermidis Serratia marcescens*
    Streptococcus pneumoniae Anaerobic species:
    Propionibacterium acnes
    *Efficacy for this organism was studied in fewer than 10 infections

    Dosage and administrations:

    The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
    Days 1 and 2 Instill one to two drops every two to four hours in the affected eye(s).
    Days 3 through 7 Instill one to two drops four times daily.
    The recommended dosage regimen for the treatment of bacterial corneal ulcer is:
    Days 1 and 2 Instill one to two drops into the affected eye every 30 minutes, while awake. Awaken at approximately four and six hours after retiring and instill one to two drops.
    Days 3 through 7 to 9 treatment completion Instill one to two drops hourly, while awake.

  • Sodium Chloride

    Composition:

    Each ml contains: Sodium Chloride 9mg

    Indications:

    1. Nasal dryness
    2. Post operative nasal dryness(after operations on the nasal  sinuses)
    3. Allergic rhinitis & Congestion due to cold of flu
    4. Thick or crusty nasal mucus
    5.  “Aging Nose” happens when the nose increases its secretions, usually due to hormone changes, particularly in women. Nasal irrigation is a great way to consistently clean out those nasal passages of the excess mucus.
    6. Cystic Fibrosis (CF) patients can also find relief by using nasal irrigation to clean the thick nasal secretions so often associated with the disease.

    Dosage and Administration of Spray:

    Bend forward and tilt your head down. Place the tip of Nozzles in the nostril and squeeze the bottle with pressure and spray the solution into the nostril. Repeat the process in both nostrils 2 -3 times a day or as directed by the physician.

  • Timolol

    COMPOSITION:

    Each ml contains:
    Timolol  BP 5mg

    Indication:

      Timitol Ophthalmic Solution is indicated in the treatment of elevated intraocular
    pressure in patients with ocular hypertension or open-angle glaucoma.

    Dosage and Administration:

    TIMITOL Ophthalmic Solution is available in concentrations of 0.25% and  0.5%. The usual starting dose is one drop of 0.5% TIMITOL in the affected eye(s) twice a day. If the clinical response is not adequate, the dosage may be changed to one drop of 0.5% solution in the affected eye(s) twice a day.    Since in some patients the pressure-lowering response to TIMITOL may require a few weeks to stabilize, evaluation should include a determination of intraocular pressure after approximately 4 weeks of treatment with TIMITOL.
    If the intraocular pressure is maintained at satisfactory levels, the dosage schedule may be changed to one drop once a day in the affected eye(s). Because of diurnal variations in intraocular pressure, satisfactory response to the once-a-day dose is best determined by measuring the intraocular pressure at different times during the day.
    Dosages above one drop of 0.5% TIMITOL twice a day generally have not been shown to produce further reduction in intraocular pressure. If the patient's intraocular pressure is still not at a satisfactory level on this regimen, concomitant therapy with other agent(s) for lowering intraocular pressure can be instituted. The concomitant use of two topical beta-adrenergic blocking agents is not recommended.